340 related articles for article (PubMed ID: 4050693)
1. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia.
Manz M; Steinbeck G; Lüderitz B
Am J Cardiol; 1985 Oct; 56(10):593-7. PubMed ID: 4050693
[TBL] [Abstract][Full Text] [Related]
2. Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
Breithardt G; Borggrefe M; Wiebringhaus E; Seipel L
Am J Cardiol; 1984 Nov; 54(9):29D-39D. PubMed ID: 6496367
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiologic effects of oral propafenone in Wolff-Parkinson-White syndrome studied by programmed electrical stimulation.
Sethi KK; Prasad GS; Mohan JC; Arora R; Khalilullah M
Indian Heart J; 1991; 43(1):5-10. PubMed ID: 1894303
[TBL] [Abstract][Full Text] [Related]
4. Effects of propafenone on induction and maintenance of atrioventricular nodal reentrant tachycardia.
Garcia-Civera R; Sanjuan R; Morell S; Ferrero JA; Miralles L; Llavador J; Lopez-Merino V
Pacing Clin Electrophysiol; 1984 Jul; 7(4):649-55. PubMed ID: 6205364
[TBL] [Abstract][Full Text] [Related]
5. Double-blind study of intravenous propafenone for paroxysmal supraventricular reentrant tachycardia.
Hammill SC; McLaran CJ; Wood DL; Osborn MJ; Gersh BJ; Holmes DR
J Am Coll Cardiol; 1987 Jun; 9(6):1364-8. PubMed ID: 3584724
[TBL] [Abstract][Full Text] [Related]
6. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
Kühlkamp V; Ickrath O; Schmid F; Mayer F; Haasis R; Seipel L
Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias.
Abdollah H; Brugada P; Green M; Wehr M; Wellens HJ
Am J Cardiol; 1984 Sep; 54(6):544-9. PubMed ID: 6433688
[TBL] [Abstract][Full Text] [Related]
8. Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate.
Kim SS; Lal R; Ruffy R
Am J Cardiol; 1986 Jul; 58(1):80-5. PubMed ID: 3728336
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of propafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
Ludmer PL; McGowan NE; Antman EM; Friedman PL
J Am Coll Cardiol; 1987 Jun; 9(6):1357-63. PubMed ID: 3294970
[TBL] [Abstract][Full Text] [Related]
10. [Electrophysiologic effects and clinical efficacy of propafenone in pediatric patients with paroxysmal supraventricular reentrant tachycardia].
Musto B; D'Onofrio A; Musto A; Cavallaro C; Marsico F
G Ital Cardiol; 1986 Apr; 16(4):336-43. PubMed ID: 3743937
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiologic effects and clinical efficacy of oral propafenone therapy in patients with ventricular tachycardia.
Chilson DA; Heger JJ; Zipes DP; Browne KF; Prystowsky EN
J Am Coll Cardiol; 1985 Jun; 5(6):1407-13. PubMed ID: 3889099
[TBL] [Abstract][Full Text] [Related]
12. [Cibenzoline: electrophysiologic effects of a new class I anti-arrhythmia agents in supraventricular tachycardia].
Pfitzner P; Manz M; Schütz R; Lüderitz B
Z Kardiol; 1989 Oct; 78(10):654-60. PubMed ID: 2686252
[TBL] [Abstract][Full Text] [Related]
13. [Clinical experience with propafenone in paroxysmal supraventricular reciprocating tachycardias].
Furlanello F; Vergara G; Dal Forno P; Disertori M; Inama G
G Ital Cardiol; 1984 May; 14(5):379-80. PubMed ID: 6468821
[TBL] [Abstract][Full Text] [Related]
14. Ethmozin. I. Effects of intravenous drug administration on paroxysmal supraventricular tachycardia in the ventricular preexcitation syndrome.
Chazov EI; Shugushev KK; Rosenshtraukh LV
Am Heart J; 1984 Sep; 108(3 Pt 1):475-82. PubMed ID: 6382988
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia.
Lai WT; Voon WC; Yen HW; Chang JS; Sheu SH; Hwang YS; Chiu HF
Am J Cardiol; 1993 Feb; 71(5):405-8. PubMed ID: 8430627
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiologic effects and antiarrhythmic efficacy of recainam in patients with supraventricular tachycardia.
Tai YT; Campbell RW; McComb JM
J Cardiovasc Pharmacol; 1991 Feb; 17(2):310-5. PubMed ID: 1709237
[TBL] [Abstract][Full Text] [Related]
17. [Injectable and oral propafenone in nodal reentry and pathways of ventricular preexcitation].
Fauchier JP; Cosnay P; Moquet B; Rouesnel P; Kapusta P; Vrancea F
Arch Mal Coeur Vaiss; 1986 Sep; 79(10):1506-14. PubMed ID: 3099684
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological effects and clinical efficacy of propafenone in children with recurrent paroxysmal supraventricular tachycardia.
Musto B; D'Onofrio A; Cavallaro C; Musto A
Circulation; 1988 Oct; 78(4):863-9. PubMed ID: 3168194
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiologic and clinical effects of intravenous and oral encainide in accessory atrioventricular pathway.
Kunze KP; Kuck KH; Schlüter M; Kuch B; Bleifeld W
Am J Cardiol; 1984 Aug; 54(3):323-9. PubMed ID: 6431796
[TBL] [Abstract][Full Text] [Related]
20. [Wolff-Parkinson-White syndrome with orthodromic supraventricular tachycardia associated with a "hyper-conductor" atrio-ventricular node. A therapeutic challenge].
Hernández González D; Iturralde Torres P; Romero L; Colín L; Villarreal A; González Hermosillo JA
Arch Inst Cardiol Mex; 1990; 60(2):175-81. PubMed ID: 2378538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]